Vasculitis

Vasculitis
Other names: Vasculitides,[1] angiitis[2]
Smaller and larger areas of bleeding into the skin on the lower limb due to medication-induced vasculitis.
Pronunciation
  • /væskjʊˈlaɪtɪs/
SpecialtyRheumatology
SymptomsFever, weight loss, tiredness, bleeding, tender blood vessels[3][4]
ComplicationsStroke, heart attacks, aortic dissection, kidney failure, coughing up blood[3]
Usual onsetVariable[4]
TypesLarge: Giant cell arteritis, Takayasu disease, Behcet disease[3][5]
Medium: Kawasaki disease, polyarteritis nodosa[3][5]
Small: Microscopic polyangiitis, granulomatosis with polyangiitis[3][5]
CausesOften unknown[3]
Diagnostic methodBlood tests, medical imaging, biopsy[5]
Differential diagnosisInfective endocarditis, histoplasmosis, gonorrhea, thrombotic thrombocytopenic purpura
TreatmentDepends on the type, often initially with steroids[3]

Vasculitis is a group of disorders that involves inflammation of blood vessels.[3][6] Symptoms may include fever, weight loss, tiredness, bleeding, and tender blood vessels.[3][4] Further symptoms may vary depending on the location and type of vessel affected.[3] Complications may include stroke, heart attacks, aortic dissection, kidney failure, and coughing up blood.[3]

There are more than 30 types of vasculitis, which may involve arteries, veins, or capillaries.[3][5] Types that involve large vessels include giant cell arteritis (GCA), Takayasu disease, and Behcet disease; types that involve medium vessels include Kawasaki disease and polyarteritis nodosa (PAN); and types that involve small vessels include microscopic polyangiitis and granulomatosis with polyangiitis (GPA).[3][5] There; however, may be overlap between these groups.[5]

The cause is often unknown, though certain cases may be triggered by an infection, medication, or other disorder.[3][5] Risk factors depend on the condition in question.[3] The underlying mechanism is often that of an autoimmune disease with neutrophils entering the inner lining of the vessel.[6][4] The diagnosis may be suspected based on blood tests, such as ESR or CRP, medical imaging, and biopsy.[3][5]

Treatment depends on the type, though steroids are often used initially.[3] About 3 per 100,000 people are newly affected by a systemic vasculitis per year in Europe and the United States.[3] In those over the age of 50 GCA newly affects about 24 per 100,000 per year.[3] Different types of disease are more common within certain age groups.[4] Overall males and females are affected with similar frequency.[2] While the condition has been described since at least the 11th century the first detailed description is attributed to Kussmaul and Maier in 1866.[7]

Signs and symptoms

Possible symptoms include:[8]

Cause

Classification

Vasculitis can be classified by the cause, the location, the type of vessel or the size of vessel.

  • Underlying cause. For example, the cause of syphilitic aortitis is infectious (aortitis simply refers to inflammation of the aorta, which is an artery.) However, the causes of many forms of vasculitis are poorly understood. There is usually an immune component, but the trigger is often not identified. In these cases, the antibody found is sometimes used in classification, as in ANCA-associated vasculitides.
  • Location of the affected vessels. For example, ICD-10 classifies "vasculitis limited to skin" with skin conditions (under "L"), and "necrotizing vasculopathies" (corresponding to systemic vasculitis) with musculoskeletal system and connective tissue conditions (under "M"). Arteritis/phlebitis on their own are classified with circulatory conditions (under "I").
  • Type or size of the blood vessels that they predominantly affect.[9] Apart from the arteritis/phlebitis distinction mentioned above, vasculitis is often classified by the caliber of the vessel affected. However, there can be some variation in the size of the vessels affected.

A small number have been shown to have a genetic basis. These include adenosine deaminase 2 deficiency and haploinsufficiency of A20.

According to the size of the vessel affected, vasculitis can be classified into:[10][11]

Major types
VasculitisAffected organsHistopathology
Cutaneous small-vessel vasculitisSkin, kidneysNeutrophils, fibrinoid necrosis
Granulomatosis with polyangiitisNose, lungs, kidneysNeutrophils, giant cells
Eosinophilic granulomatosis with polyangiitisLungs, kidneys, heart, skinHistiocytes, eosinophils
Behçet's diseaseCommonly sinuses, brain, eyes and skin; can affect other organs such as lungs, kidneys, jointsLymphocytes, macrophages, neutrophils
Kawasaki diseaseSkin, heart, mouth, eyesLymphocytes, endothelial necrosis
Buerger's diseaseLeg arteries and veins (gangrene)Neutrophils, granulomas
"Limited" granulomatosis with polyangiitis vasculitisCommonly sinuses, brain, and skin; can affect other organs such as lungs, kidneys, joints;

Takayasu's arteritis, polyarteritis nodosa and giant cell arteritis mainly involve arteries and are thus sometimes classed specifically under arteritis.

Furthermore, there are many conditions that have vasculitis as an accompanying or atypical feature, including:

In pediatric patients varicella inflammation may be followed by vasculitis of intracranial vessels. This condition is called post varicella angiopathy and this may be responsible for arterial ischaemic strokes in children.[12]

Several of these vasculitides are associated with antineutrophil cytoplasmic antibodies.[13] These are:

Diagnosis

Micrograph showing a vasculitis (Eosinophilic granulomatosis with polyangiitis). H&E stain.
Severe vasculitis of the major vessels, displayed on FDG-PET/CT
  • Some types of vasculitis display leukocytoclasis, which is vascular damage caused by nuclear debris from infiltrating neutrophils.[14] It typically presents as palpable purpura.[14] Conditions with leucocytoclasis mainly include hypersensitivity vasculitis (also called leukocytoclastic vasculitis) and cutaneous small-vessel vasculitis (also called cutaneous leukocytoclastic angiitis).
  • An alternative to biopsy can be an angiogram (x-ray test of the blood vessels). It can demonstrate characteristic patterns of inflammation in affected blood vessels.
  • 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)has become a widely used imaging tool in patients with suspected Large Vessel Vasculitis, due to the enhanced glucose metabolism of inflamed vessel walls.[15] The combined evaluation of the intensity and the extension of FDG vessel uptake at diagnosis can predict the clinical course of the disease, separating patients with favourable or complicated progress.[16]
  • Acute onset of vasculitis-like symptoms in small children or babies may instead be the life-threatening purpura fulminans, usually associated with severe infection.
Laboratory investigation[17]
DiseaseSerologic testAntigenAssociated laboratory features
Systemic lupus erythematosusANA including antibodies to dsDNA and ENA [including SM, Ro (SSA), La (SSB), and RNP]Nuclear antigensLeukopenia, thrombocytopenia, Coombs' test, complement activation: low serum concentrations of C3 and C4, positive immunofluorescence using Crithidia luciliae as substrate, antiphospholipid antibodies (i.e. anticardiolipin, lupus anticoagulant, false-positive VDRL)
Goodpasture's diseaseAnti-glomerular basement membrane antibodyEpitope on noncollagen domain of type IV collagen
Small vessel vasculitis
Microscopic polyangiitisPerinuclear antineutrophil cytoplasmic antibodyMyeloperoxidaseElevated CRP
Granulomatosis with polyangiiitisCytoplasmic antineutrophil cytoplasmic antibodyProteinase 3 (PR3)Elevated CRP
Eosinophilic granulomatosis with polyangiitisperinuclear antineutrophil cytoplasmic antibody in some casesMyeloperoxidaseElevated CRP and eosinophilia
IgA vasculitis (Henoch-Schönlein purpura)None
CryoglobulinemiaCryoglobulins, rheumatoid factor, complement components, hepatitis C
Medium vessel vasculitis
Classical polyarteritis nodosaNoneElevated CRP and eosinophilia
Kawasaki's DiseaseNoneElevated CRP and ESR

In this table: ANA = Antinuclear antibodies, CRP = C-reactive protein, ESR = Erythrocyte Sedimentation Rate, dsDNA = double-stranded DNA, ENA = extractable nuclear antigens, RNP = ribonucleoproteins; VDRL = Venereal Disease Research Laboratory

Treatment

Treatments are generally directed toward stopping the inflammation and suppressing the immune system. Typically, corticosteroids such as prednisone are used. Additionally, other immune suppression medications, such as cyclophosphamide and others, are considered. In case of an infection, antimicrobial agents including cephalexin may be prescribed. Affected organs (such as the heart or lungs) may require specific medical treatment intended to improve their function during the active phase of the disease.

References

  1. ↑ "Vasculitis - Definition from the Merriam-Webster Online Dictionary". Archived from the original on 1 July 2016. Retrieved 8 January 2009.
  2. 1 2 "Vasculitis". NORD (National Organization for Rare Disorders). Archived from the original on 6 February 2021. Retrieved 18 February 2021.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Jatwani, S; Goyal, A (January 2020). "Vasculitis". PMID 31424770. {{cite journal}}: Cite journal requires |journal= (help)
  4. 1 2 3 4 5 "Vasculitis". www.nhlbi.nih.gov. NHLBI, NIH. Archived from the original on 11 February 2021. Retrieved 18 February 2021.
  5. 1 2 3 4 5 6 7 8 9 "Overview of Vasculitis - Musculoskeletal and Connective Tissue Disorders". Merck Manuals Professional Edition. Archived from the original on 3 April 2015. Retrieved 18 February 2021.
  6. 1 2 "Glossary of dermatopathological terms. DermNet NZ". Archived from the original on 20 December 2008. Retrieved 8 January 2009.
  7. ↑ Hendaoui, Lotfi; Stanson, Anthony W.; Bouhaouala, M. Habib; Joffre, Francis (2011). Systemic Vasculitis: Imaging Features. Springer Science & Business Media. p. 8. ISBN 978-3-642-02484-9. Archived from the original on 10 July 2021. Retrieved 18 February 2021.
  8. ↑ "The Johns Hopkins Vasculitis Center - Symptoms of Vasculitis". Archived from the original on 27 February 2009. Retrieved 7 May 2009.
  9. ↑ Jennette JC, Falk RJ, Andrassy K, et al. (1994). "Nomenclature of systemic vasculitides. Proposal of an international consensus conference". Arthritis Rheum. 37 (2): 187–92. doi:10.1002/art.1780370206. PMID 8129773.
  10. ↑ "Overview of Vasculitis". Archived from the original on 3 April 2015. Retrieved 5 October 2016.
  11. ↑ Gündüz, Özgür (18 October 2011). "Histopathological Evaluation of Behçet's Disease and Identification of New Skin Lesions". Pathology Research International. 2012: 1–7. doi:10.1155/2012/209316. ISSN 2090-8091. PMC 3199096. PMID 22028988.
  12. ↑ Nita R Sutay, Md Ashfaque Tinmaswala, Shilpa Hegde . "International Journal of Medical Research and Health Sciences | 404 Page". Archived from the original on 17 November 2015. Retrieved 19 August 2015.
  13. ↑ Millet A, Pederzoli-Ribeil M, Guillevin L, Witko-Sarsat V, Mouthon L (2013) Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis
  14. 1 2 A Brooke W Eastham, Ruth Ann Vleugels and Jeffrey P Callen. "Leukocytoclastic Vasculitis". Medscape. Archived from the original on 19 October 2019. Retrieved 8 November 2019. Updated: Oct 25, 2018
  15. ↑ Maffioli L, Mazzone A (2014). "Giant-Cell Arteritis and Polymyalgia Rheumatica". NEJM. 371 (17): 1652–1653. doi:10.1056/NEJMc1409206. PMC 4277693. PMID 25337761.
  16. ↑ Dellavedova L, Carletto M, Faggioli P, Sciascera A, Del Sole A, Mazzone A, Maffioli LS (2015). "The prognostic value of baseline 18F-FDG PET/CT in steroid-naïve large-vessel vasculitis: introduction of volume-based parameters". European Journal of Nuclear Medicine and Molecular Imaging. 55 (2): 340–8. doi:10.1007/s00259-015-3148-9. PMID 26250689.
  17. ↑ Burtis CA, Ashwood ER, Bruns DE (2012). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 5th edition. Elsevier Saunders. p. 1568. ISBN 978-1-4160-6164-9.
Classification
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.